Clinical trials in Novara – page 212

Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.

• Advanced breast cancer therapies
• Chronic myeloid leukemia treatments
• Non-small cell lung cancer interventions

Studies evaluating combination therapies and targeted treatments to improve patient outcomes.

Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.

• Heart failure risk reduction
• Cardiovascular death prevention
• Chronic kidney disease management

Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.

Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.

• Biomarker-guided treatments
• Long-term safety evaluations
• Innovative therapeutic combinations

Focus on developing targeted therapies for better disease management and patient care.